Suppr超能文献

信任,但要核实——评“部分解决方案:食品公司的监管俘获和合法性策略”

Trust, but Verify Comment on "'Part of the Solution': Food Corporation Strategies for Regulatory Capture and Legitimacy".

机构信息

London School of Hygiene and Tropical Medicine, London, UK.

出版信息

Int J Health Policy Manag. 2022 Dec 6;11(11):2727-2731. doi: 10.34172/ijhpm.2022.7008. Epub 2022 Feb 26.

Abstract

According to Lacy-Nichols and Williams, the food industry is increasingly forestalling regulation with incremental concessions and co-option of policy-making discourses and processes; bolstering their legitimacy via partnerships with credible stakeholders; and disarming critics by amending their product portfolios whilst maintaining high sales volumes and profits. Their assessment raises a number of fundamental philosophical questions that we must address in order to form an appropriate public health response: is it appropriate to treat every act of corporate citizenship with cynicism? If voluntary action leads to better health outcomes, does it matter whether profits are preserved? How should we balance any short-term benefits from industry-led reforms against the longer-term risk stemming from corporate capture of policy-making networks? I argue for a nuanced approach, focused on carefully defined health outcomes; allowing corporations the benefit of the doubt, but implementing robust binding measures the moment voluntary actions fail to meet independently set objectives.

摘要

根据 Lacy-Nichols 和 Williams 的说法,食品行业越来越多地通过逐步让步和对政策制定话语和过程的选择性采用来阻碍监管;通过与可信利益相关者建立合作伙伴关系来增强其合法性;通过修改产品组合来削弱批评者,同时保持高销售额和利润。他们的评估提出了一些我们必须解决的基本哲学问题,以便形成适当的公共卫生应对措施:是否应该对企业公民的每一个行为都持怀疑态度?如果自愿行动能带来更好的健康结果,那么利润是否得到保留是否重要?我们应该如何平衡行业主导的改革带来的任何短期利益与企业对政策制定网络的长期影响?我主张采取一种细致入微的方法,重点关注精心定义的健康结果;给予企业一定的信任,但一旦自愿行动未能达到独立设定的目标,就立即实施强有力的约束措施。

相似文献

1
Trust, but Verify Comment on "'Part of the Solution': Food Corporation Strategies for Regulatory Capture and Legitimacy".
Int J Health Policy Manag. 2022 Dec 6;11(11):2727-2731. doi: 10.34172/ijhpm.2022.7008. Epub 2022 Feb 26.
6
The Foundations of Corporate Strategies Comment on "'Part of the Solution': Food Corporation Strategies for Regulatory Capture and Legitimacy".
Int J Health Policy Manag. 2022 Dec 6;11(11):2732-2735. doi: 10.34172/ijhpm.2022.7174. Epub 2022 Apr 6.
7
"Part of the Solution": Food Corporation Strategies for Regulatory Capture and Legitimacy.
Int J Health Policy Manag. 2021 Dec 1;10(12):845-856. doi: 10.34172/ijhpm.2021.111.
8
Food industry political practices in Chile: "the economy has always been the main concern".
Global Health. 2020 Oct 27;16(1):107. doi: 10.1186/s12992-020-00638-4.

引用本文的文献

1
Multisectoral action to address noncommunicable diseases: lessons from three country case studies.
Front Public Health. 2024 Feb 21;12:1303786. doi: 10.3389/fpubh.2024.1303786. eCollection 2024.
2
Political Economy and Research Silos: A Response to the Recent Commentaries.
Int J Health Policy Manag. 2023;12:7995. doi: 10.34172/ijhpm.2023.7995. Epub 2023 Apr 10.

本文引用的文献

2
Implementation of non-communicable disease policies from 2015 to 2020: a geopolitical analysis of 194 countries.
Lancet Glob Health. 2021 Nov;9(11):e1528-e1538. doi: 10.1016/S2214-109X(21)00359-4.
3
"Part of the Solution": Food Corporation Strategies for Regulatory Capture and Legitimacy.
Int J Health Policy Manag. 2021 Dec 1;10(12):845-856. doi: 10.34172/ijhpm.2021.111.
4
The sugar content of foods in the UK by category and company: A repeated cross-sectional study, 2015-2018.
PLoS Med. 2021 May 18;18(5):e1003647. doi: 10.1371/journal.pmed.1003647. eCollection 2021 May.
5
Power and the commercial determinants of health: ideas for a research agenda.
BMJ Glob Health. 2021 Feb;6(2). doi: 10.1136/bmjgh-2020-003850.
7
Portugal's voluntary food reformulation agreement and the WHO reformulation targets.
J Glob Health. 2019 Dec;9(2):020315. doi: 10.7189/jogh.09.020315.
8
Corporate profits versus spending on non-communicable disease prevention: an unhealthy balance.
Lancet Glob Health. 2019 Nov;7(11):e1482-e1483. doi: 10.1016/S2214-109X(19)30399-7.
9
The Corporate Permeation Index - A tool to study the macrosocial determinants of Non-Communicable Disease.
SSM Popul Health. 2019 Feb 27;7:100361. doi: 10.1016/j.ssmph.2019.100361. eCollection 2019 Apr.
10
Revisiting the Corporate and Commercial Determinants of Health.
Am J Public Health. 2018 Sep;108(9):1167-1170. doi: 10.2105/AJPH.2018.304510. Epub 2018 Jul 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验